Cannabis Stocks in 2026: What Is Listed, What Is Next and How the Market Trades
Why are cannabis listings so relevant in 2026?
Why are cannabis listings so relevant in 2026?
Trulieve’s uplisting to the NYSE, the first of its kind in US history, has undoubtedly caught the attention of every large North American cannabis operator.
Cannabis stocks have, for the last five years or so, represented one of, if not the worst-performing, niche categories on any exchange.
Having spent over 30 years in advisory roles in financial markets prior to entering the cannabinoid industry, I lived through many hyperbolic boom/bust market cycles.
For much of the past five years, the cannabis industry has been defined by disappointment.
BoC Cannabis Index closes +0.61% but breadth turns negative as 23 of 38 names fall; WM Technology surges 14% while REFI leads losers down 5%.
BoC Cannabis Index +1.67% on broad strength; Curaleaf +9.4% leads a 27-stock advance, IIPR -4.3% the day’s worst.
BoC Cannabis Index gains +1.26% as Innovative Industrial Properties surges +14.03%, lifting US MSOs and ETFs in a synchronised cannabis rally.
Cannabis stocks closed broadly higher Thursday with the BoC Cannabis Index up 2.65%, every ETF gaining at least 3.9%, and Ayr Wellness pacing the universe at +30.7% even as several US MSOs lagged the rally.